Area of research
Molecular Biology · Surgery
Research interest
Research interests include RNA modifications and cancer, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics, and Nanoplatforms for cancer theranostics.
A Manganese‐Based Nanodriver Coordinates Tumor Prevention and Suppression through STING Activation in Glioblastoma
A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers
1512MO Perioperative camrelizumab (C) combined with rivoceranib (R) and chemotherapy (chemo) versus chemo for locally advanced resectable gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The first interim analysis of a randomized, phase III trial (DRAGON IV)
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics Analysis
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
Tumor Receptor-Mediated In Vivo Modulation of the Morphology, Phototherapeutic Properties, and Pharmacokinetics of Smart Nanomaterials
Odanacatib, A Cathepsin K‐Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases
A Small Molecule, Odanacatib, Inhibits Inflammation and Bone Loss Caused by Endodontic Disease